Matthieu Meryet-Figuiere
Overview
Explore the profile of Matthieu Meryet-Figuiere including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
428
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schwalen F, Ghadi C, Ibazizene L, Khan S, Sopkova-de Oliveira Santos J, Weiswald L, et al.
J Med Chem
. 2025 Jan;
68(2):915-928.
PMID: 39806871
UBE2N protein belongs to the UE2s family and plays a crucial role in DNA repair, making it an exciting target for the development of innovative anticancer therapies. With the aim...
2.
Thorel L, Divoux J, Lequesne J, Babin G, Morice P, Florent R, et al.
BMC Cancer
. 2024 Jun;
24(1):701.
PMID: 38849726
Background: Ovarian cancer is the first cause of death from gynecological malignancies mainly due to development of chemoresistance. Despite the emergence of PARP inhibitors, which have revolutionized the therapeutic management...
3.
Renier M, Hippert J, Louis-Bastien W, Tual S, Meryet-Figuiere M, Vigneron N, et al.
Occup Environ Med
. 2024 Jan;
81(2):75-83.
PMID: 38199811
Background: Ovarian cancer is rare with a poor prognosis and few established risk factors. Hormones and reproductive factors significantly impact its development, suggesting a potential link with endocrine disrupters. Methods:...
4.
Thorel L, Morice P, Paysant H, Florent R, Babin G, Thomine C, et al.
J Exp Clin Cancer Res
. 2023 Oct;
42(1):260.
PMID: 37803448
Background: In the era of personalized medicine, the establishment of preclinical models of cancer that faithfully recapitulate original tumors is essential to potentially guide clinical decisions. Methods: We established 7...
5.
Boulanger M, De Graaf L, Pons R, Bouchart V, Bureau M, Lecluse Y, et al.
Ann Work Expo Health
. 2023 Aug;
67(8):965-978.
PMID: 37619214
Context: There is a lack of data on pesticide exposure levels during spraying with a knapsack, while it could have important implications for their users' health. Methods: We assessed levels...
6.
Ahmad M, Weiswald L, Poulain L, Denoyelle C, Meryet-Figuiere M
J Exp Clin Cancer Res
. 2023 Jul;
42(1):173.
PMID: 37464436
Cancer is the main cause of death worldwide and metastasis is a major cause of poor prognosis and cancer-associated mortality. Metastatic conversion of cancer cells is a multiplex process, including...
7.
Talibov M, Tual S, Morlais F, Meryet-Figuiere M, Boulanger M, Bouvier V, et al.
Cancer Epidemiol
. 2022 Mar;
78:102125.
PMID: 35303617
Objectives: Specific farming types and tasks have rarely been studied in relation to colorectal cancer (CRC). We evaluated associations between 5 types of livestock and 13 types of crops in...
8.
Renier M, Busson A, Boulanger M, Piel C, Pons R, Tual S, et al.
Int J Cancer
. 2022 Jan;
150(11):1792-1803.
PMID: 35048371
Sarcomas are a heterogeneous group of tumors whose incidence is nearly 5 per 100 000 inhabitants in Europe. Their causes are poorly understood, although occupational exposures (especially farming and pesticides)...
9.
Tual S, Lemarchand C, Giovannini J, Boulanger M, Meryet-Figuiere M, Talibov M, et al.
Cancer Causes Control
. 2022 Jan;
33(2):331-342.
PMID: 34984593
Purpose: An important challenge in epidemiology is to ensure the reliability of collected data. Very few studies have been conducted in farming populations. We assessed the reliability of self-reported data...
10.
Meryet-Figuiere M, Vernon M, Andrianteranagna M, Lambert B, Brochen C, Issartel J, et al.
Cancers (Basel)
. 2021 Aug;
13(16).
PMID: 34439123
The identification of miRNAs' targets and associated regulatory networks might allow the definition of new strategies using drugs whose association mimics a given miRNA's effects. Based on this assumption we...